Preparation of Peptide-Loaded Dendritic Cells for Cancer Immunotherapy

Author： Morse Michael A.   Clay Tim   Colling Kirsten   Lyerly H. Kim  

Publisher： Humana Press, Inc

ISSN： 1073-6085

Source： Molecular Biotechnology, Vol.25, Iss.1, 2003-09, pp. : 95-100

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Exploiting dendritic cells for active immunotherapy of cancer and chronic infections

By O’Neill David   Bhardwaj Nina  

Molecular Biotechnology, Vol. 36, Iss. 2, 2007-06 ,pp. : 131-141

Humana Press, Inc

Access to resources Recommend Favorite

The use of BRM-activated killer cells in adoptive immunotherapy: A pilot study with nine advanced cancer patients

By Ebina T.  

Biotherapy, Vol. 11, Iss. 4, 1998-01 ,pp. : 241-253

Springer Publishing Company

Access to resources Recommend Favorite

A Novel Method for Modification of Tumor Cells with Bacterial Superantigen with a Heterobifunctional Cross-Linking Agent in Immunotherapy of Cancer

By Shimizu Motomu   Matsuzawa Akio   Takeda Yasutaka  

Molecular Biotechnology, Vol. 25, Iss. 1, 2003-09 ,pp. : 89-94

Humana Press, Inc

Access to resources Recommend Favorite

Modification of Tumor Cells with Fas (CD95) Antigen Gene and Fas Ligand (CD95L) Gene Transfection by Electroporation for Immunotherapy of Cancer

By Shimizu Motomu   Yoshimoto Takayuki   Matsuzawa Akio   Takeda Yasutaka  

Molecular Biotechnology, Vol. 25, Iss. 1, 2003-09 ,pp. : 79-88

Humana Press, Inc

Access to resources Recommend Favorite

Paclitaxel Loaded Fibrinogen Coated CdTe/ZnTe Core Shell Nanoparticles for Targeted Imaging and Drug Delivery to Breast Cancer Cells

By Rejinold N. Sanoj   Baby Thejus   Nair Shantikumar V.   Jayakumar R.  

Journal of Biomedical Nanotechnology, Vol. 9, Iss. 10, 2013-10 ,pp. : 1657-1671

American Scientific Publishers

Access to resources Recommend Favorite